Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RBD1119
- Development stage
- Phase 1
- Lead developer
- Suzhou Ribo Life Science
- Modality
- Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
- Administration
- Subcutaneous
01
Overview
**RBD1119** is an investigational small interfering RNA (siRNA) drug developed by Suzhou Ribo Life Science for the potential treatment of **thromboembolism** and other cardiovascular disorders. It is designed to target the intrinsic coagulation pathway, with clinical studies measuring its effects on blood clotting parameters in healthy volunteers. The drug is administered via subcutaneous injection and is currently in Phase 1 clinical trials to assess safety, pharmacokinetics, pharmacodynamics, and tolerability in humans. Research is driven by the goal of providing novel therapies for bleeding or clotting disorders[1][2][5].
Beyond the preview
Go deeper on RBD1119.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RBD1119.